Meyer Handelman Co. Invests $1.39 Million in Axon Enterprise, Inc $AXON

Meyer Handelman Co. acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 2,485 shares of the biotechnology company’s stock, valued at approximately $1,393,000.

A number of other hedge funds also recently made changes to their positions in AXON. Creative Financial Designs Inc. ADV purchased a new position in Axon Enterprise in the fourth quarter worth $28,000. Camelot Portfolios LLC bought a new position in Axon Enterprise in the fourth quarter valued at $30,000. AlphaCentric Advisors LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at about $34,000. Darwin Wealth Management LLC purchased a new stake in Axon Enterprise during the second quarter valued at about $37,000. Finally, Strive Financial Group LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at about $41,000. 79.08% of the stock is owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 13,000 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the transaction, the president owned 169,125 shares in the company, valued at approximately $82,609,106.25. The trade was a 7.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the transaction, the insider directly owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 68,989 shares of company stock worth $36,016,932 over the last ninety days. 4.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on AXON. Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a report on Thursday, June 25th. JPMorgan Chase & Co. raised their price objective on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, July 22nd. Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Thursday, August 6th. Finally, Barclays upped their target price on Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $730.92.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $612.83 on Friday. The firm has a market cap of $49.78 billion, a PE ratio of 254.29, a price-to-earnings-growth ratio of 12.56 and a beta of 1.39. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $794.29. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. The business has a 50 day moving average price of $526.06 and a 200-day moving average price of $474.40.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. During the same quarter last year, the business earned $2.12 earnings per share. The business’s revenue was up 35.3% on a year-over-year basis. Equities research analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon raised its full-year 2026 revenue-growth outlook to 32%–34%, supported by approximately $15.1 billion in future contracted bookings and strong momentum in connected devices, AI-enabled software and counter-drone offerings. Second-quarter revenue increased 35.3% year over year to $904.4 million and exceeded analyst expectations. Axon Enterprise Is Up 17.8% After Raising 2026 Revenue Outlook
• Positive Sentiment: Northland Securities raised its FY2027 EPS forecast to $6.49 from $5.53. The firm also increased estimates for Q1, Q2, Q3 and Q4 2027, suggesting stronger expected earnings momentum beyond 2026.
• Positive Sentiment: The company’s second-quarter adjusted earnings and revenue surpassed Wall Street expectations, while management highlighted broad demand for Axon’s public-safety technology ecosystem. The 5 Most Interesting Analyst Questions From Axon’s Q2 Earnings Call
• Neutral Sentiment: Northland reduced its FY2026 EPS estimate to $3.12 from $3.26 and lowered its Q4 2026 forecast to $1.29 from $1.55, partly offsetting the more optimistic 2027 outlook.
• Negative Sentiment: Despite strong sales, quarterly net income fell to $29.4 million from $36.1 million a year earlier, and diluted EPS declined to $0.36 from $0.44. Investors remain concerned about margins, elevated costs, debt and Axon’s very high valuation. Should You Buy, Hold or Sell AXON Stock Post Q2 Earnings Release?
• Negative Sentiment: Recent insider selling has added pressure and increased investor caution around the stock’s valuation. Axon Enterprise Trading Down Following Insider Selling

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.